Batelapine (developmental code name CGS-13429) is a structural analogue of clozapine which was investigated as a potential antipsychotic.[1][2]
Clinical data | |
---|---|
Other names | CGS-13429 |
Routes of administration | By mouth |
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | 8.1 Hours |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C16H20N6 |
Molar mass | 296.378 g·mol−1 |
3D model (JSmol) |
|
| |
|